Top Telecom Pick: Should You Choose Telus or BCE?
Successful dividend investing in the stock market is all about making high-quality picks from the right sectors that can distribute payouts comfortably, supported by solid underlying businesses. Looking into stock from the top companies in industries that can align with your passive income goals is a good way to go about this.
The Canadian telecom sector is highly consolidated and well-established, and has a few recession-resistant names that many investors like to own in their portfolios. Most of the top telecom stocks offer shareholders an attractive dividend yield supported by solid fundamentals.
Two Canadian telcos are the top considerations for many investors. Each has its own strategic approach to respond to changing market conditions. Dividend-centric investors should consider these carefully to make a well-informed decision before investing in Canadian telecom stocks.
Today, we'll take a good look at Telus Corp. (TSX:T) and BCE Inc. (TSX:BCE) to help you determine which might be the better pick for your self-directed portfolio.
Telus is one of the Big Three telcos in the country. Boasting a $34.3 billion market cap, it has over 9 million mobile customers across the country, accounting for roughly a third of the market. The company provides internet, TV, and landline services. It has also recently started upgrading from its legacy copper network to fibre optic cables to offer better value for money to customers. Besides this, Telus has several subsidiaries operating across different sectors, including agriculture, healthcare, security, and international business services.
As of this writing, Telus stock trades for $22.65 per share and boasts a 7.4% dividend yield. Despite high-yielding dividends, its payout ratio is in the reliable 60–75% of free cash flow range. The company's diversified revenue streams, increased earnings, and sustainable payout ratio make it an attractive investment to consider.
BCE is another one of the Big Three, boasting a $29.7 billion market capitalization. It offers wireless and internet services, broadband, landline services, and has a considerable media segment that holds digital media, TV, and radio assets. BCE recently announced a 56% dividend cut, effectively slashing the payouts to relieve itself from double-digit yields that we are seeing of late. The dividend cut did not go well with plenty of investors, but it might be a good decision.
Slashing payouts to more sustainable levels means that the company has better financial flexibility to fuel future growth. The more the company can grow, the better returns it can offer to investors in the long run. Being the biggest driving force behind 5G technology in Canada, BCE could benefit from having better financials. As of this writing, it trades for $32.60 per share and boasts a 5.4% dividend yield.
Dividend-focused investors seeking immediate returns might not appreciate the dividend cut announced by BCE. However, those with a long-term investment horizon might appreciate the change because it lets the telco improve its financials over time at the cost of lower dividends for the time being.
Telus offers the promise of growth through dividends that it does not plan to cut. It also has the backing of several diversified revenue streams that might make payouts more sustainable for the company.
Between the two, it is difficult to make the wrong decision for your self-directed portfolio. If you're seeking higher-yielding immediate returns through dividends, Telus wins. If you're willing to invest with plenty of patience for potentially better long-term returns, BCE might be a better pick.
The post Top Telecom Pick: Should You Choose Telus or BCE? appeared first on The Motley Fool Canada.
Before you buy stock in BCE, consider this:
The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and BCE wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.
Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,927.94!*
Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 30 percentage points since 2013*.
See the Top Stocks * Returns as of 6/23/25
More reading
10 Stocks Every Canadian Should Own in 2025 [PREMIUM PICKS]
Market Volatility Toolkit
A Commonsense Cash Back Credit Card We Love
Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends TELUS. The Motley Fool has a disclosure policy.
2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
7 minutes ago
- Hamilton Spectator
Loblaw's Q2 profit rises as shoppers continue to flock to discount
A slew of new discount stores helped push profit at Loblaw Cos. Ltd. higher in the second quarter, as shoppers continue to seek lower-priced products, a trend the company's CEO says will remain for the long term. 'Our hard discount stores: They're doing well and they're still leading and doing better compared to the rest of the portfolio,' Loblaw chief executive Per Bank told analysts on a conference call Thursday. He said Canadians are increasingly seeking promotions and private-label products, driving up sales at the grocer's discount stores. 'The global shift toward discount retail is a long-term trend and we are leading it here in Canada,' Bank said. Earlier this year, Loblaw announced its plan to spend $2.2 billion, opening 80 new grocery and pharmacy stores, with about 50 of them being smaller-format discount stores. So far, the company has opened 20 new stores and 23 new pharmacy clinics. The parent company of Loblaws and Shoppers Drug Mart said its net earnings available to common shareholders amounted to $714 million or $2.37 per diluted share for the quarter ended June 14. The result was up from a profit of $457 million or $1.48 per diluted share in the second quarter of 2024. Despite the upbeat quarterly results, Loblaw did not upgrade its guidance, with chief financial officer Richard Dufresne saying it was too early to do so. 'There's still a lot of uncertainty out there, so we thought it'd be more prudent to wait,' he told analysts. The company could update its financial guidance in its third-quarter results, Dufresne said. Bank said the company is continuing to strengthen its local supply chain, onboarding another 130 Canadian vendors onto its network. The ongoing tariff dispute with the United States and the trend of shoppers favouring Canadian made products has led many grocers to increase their local offerings. Earlier this year, Loblaw began highlighting domestic products in its stores while also marking products that have seen price hikes due to tariffs with a 'T' symbol. It also added a 'swap and shop' feature to its loyalty app to help shoppers find Canadian products more easily. 'As intended, it has helped our customers by clearly identifying tariff items, supporting Canada, and saving money,' Bank said. Sales volume on items labelled with a 'T' were down more than 15 per cent, he said. 'There's some misconception that the tariffs are no longer a factor in grocery,' he said. 'Nothing could actually be further from the truth.' Bank said about a third of all supplier cost increase requests are tariff related. On an adjusted basis, Loblaw said it earned $2.40 per diluted share in its latest quarter, up from an adjusted profit of $2.15 per diluted share a year earlier. Analysts on average had expected an adjusted profit of $2.33 per diluted share, according to LSEG Data & Analytics. Revenue for the quarter totalled $14.7 billion, up from $13.9 billion, as food retail same-store sales rose by 3.5 per cent. The company said sales growth was driven by new store openings and improved same-store sales, with 'impactful promotions driving higher customer engagement.' Drug retail same-store sales rose 4.1 per cent, with pharmacy and health care services same-store sales up 6.2 per cent, and front store same-store sales increasing 1.7 per cent. RBC analyst Irene Nattel called it 'another solid quarter' for the company, noting food revenues were 'a string bean ahead of forecast.' Separately, Loblaw announced a four-for-one stock split, citing continued affordability and accessibility of its shares for investors. Over the past year, Loblaw shares have risen more than 30 per cent to trade just above $220. This report by The Canadian Press was first published July 24, 2025. Companies in this story: (TSX: L)
Bloomberg
8 minutes ago
- Bloomberg
Can This New US-Canada Bridge Survive Trump's Trade War?
For years, leaders on either side of the Detroit River eagerly awaited the completion of the new Gordie Howe International Bridge, a $4.7 billion structure conceived as a means of strengthening US-Canada relations. Financed entirely by the Canadian government, it promises to ease gridlock on a nearby cross-border bridge and to be a boost for the regional supply chain. But as the bridge inches closer to its opening date later this year, its economic prospects are clouded by President Donald Trump's trade war and his policy attacks on Canada. Still, officials remain hopeful that the bridge will lure tourists (and trade) back to the US — and maybe even become an attraction itself, contributor Vince Guerrieri writes. Today on CityLab:
Yahoo
36 minutes ago
- Yahoo
Bonds Fall on Jobs Strength as Stocks Grind Higher: Markets Wrap
(Bloomberg) -- Treasuries fell as jobless claims hit the lowest since April, underscoring labor-market strength that's keeping the Federal Reserve on hold. Stocks hovered near record highs amid a deluge of corporate earnings. Trump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in US The High Costs of Trump's 'Big Beautiful' New Car Loan Deduction Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom Can This Bridge Ease the Troubled US-Canadian Relationship? Bonds dropped for a second day, with 10-year yields rising two basis points to 4.40%. Traders slightly pared bets on Fed cuts, projecting less than two reductions this year. The S&P 500 edged higher, with Alphabet Inc. up and Tesla Inc. down after their results. As European policymakers tempered expectations of policy easing, German bunds slid. The dollar and the euro wavered. Subscribe to the Stock Movers Podcast on Apple, Spotify and other Podcast Platforms. Read: 10-Year TIPS Auction Draws 1.985%, Near WI Yield at Bid Deadline Applications for US unemployment benefits fell for a sixth straight week - the longest stretch of declines since 2022. The characterization of the labor market will be a key feature of next week's Fed meeting. To Bret Kenwell at eToro, while the labor market is not firing on all cylinders, it's not showing signs of distress either. If next week's jobs data give another reassuring nod to the labor market, he says investors may breathe a further sigh of relief. 'There are still few signs of major cracks in the labor market,' said Chris Larkin at E*Trade from Morgan Stanley. 'And if that picture remains intact, the Fed has one less reason to cut interest rates.' President Donald Trump will visit the Fed Thursday to tour the construction site he's criticized for cost overruns amid his escalating attacks on Fed Chair Jerome Powell for not cutting rates. The S&P 500's record-setting spree may be stoking concerns about inflated share prices and a revival of meme-stock froth, but JPMorgan Chase & Co.'s trading desk isn't concerned. Rather, it expects the furious rally in US equities to keep going. 'While bullishness is not yet consensus, client conversations reveal that even those that skewed bearish are throwing in the towel,' the bank's head of global market intelligence Andrew Tyler said Thursday in a note ahead of the market open. Trading desks at firms including Goldman Sachs Group Inc. and Citadel Securities are telling clients to buy cheap hedges against potential losses in US stocks as a slew of risks loom over the market's record advance. US margin debt, a measure showing how much investors are borrowing to buy stocks on the New York Stock Exchange, is starting to run too hot — a potentially concerning sign for the credit market, according to credit strategists at Deutsche Bank AG. The market euphoria may continue if there are unexpected tariff reductions or a more dovish stance by the Fed than investors anticipate, the strategists said. US stocks face near-term risk as the market is too complacent about tariffs and the related backlash, according to BNP Paribas Asset Management strategist Chi Lo. On the trade front, Trump suggested he would not go below 15% as he sets so-called reciprocal tariff rates ahead of an Aug. 1 deadline, an indication that the floor for the increased levies was rising. While some investors are concerned about 'frothiness,' Craig Johnson at Piper Sandler says that, from a technical point of view, that this is not the case when looking 'down-cap' from the heavy-weights in the S&P 500 and Nasdaq indices. 'We believe that this bull market is broadening out in terms of participation,' he said. In a sign of how breadth remains, the NYSE advance-decline line, a popular indicator that tracks the number of securities rising minus the number falling on the exchange each day, hit fresh highs. Corporate Highlights: Elon Musk warned of difficult times ahead for Tesla Inc. following one of the carmaker's worst stretches since it first started producing electric sedans over a dozen years ago. Alphabet Inc. said demand for artificial intelligence products boosted quarterly sales, and now requires an extreme increase in capital spending — heightening pressure on the company to justify the cost of keeping up in the AI race. International Business Machines Corp. reported weaker-than-expected sales in its closely watched software segment, disappointing investors who have grown increasingly optimistic about the business. Microsoft Corp. said a Chinese hacking group is exploiting security vulnerabilities in the company's SharePoint servers to deploy ransomware, following a cyberattack discovered last week that has affected hundreds of entities around the world. UnitedHealth Group Inc. is responding to criminal and civil requests from the US Department of Justice about its Medicare practices, the company said, confirming reports of probes that have added to mounting challenges for the largest US health insurer. Union Pacific Corp., North America's largest railroad, is in advanced discussions with Norfolk Southern Corp. about a potential tie-up in what would be the industry's largest deal ever. LVMH sales fell as shoppers reined in purchases of costly Louis Vuitton bags and Dior jackets, a sign the luxury titan remains stuck in its post-pandemic slump. American Airlines Group Inc. scaled back its earnings outlook amid deep fare discounts offered to woo reluctant travelers back on flights during a slump in consumer demand. Southwest Airlines Co. expects economic turmoil to erase as much as $1 billion of its annual pre-tax profit this year, prompting the US airline to offer shareholders a much-reduced outlook for 2025. Union Pacific Corp., North America's largest railroad, is in advanced discussions with Norfolk Southern Corp. about a potential tie-up in what would be the industry's largest deal ever. The Food and Drug Administration won't sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to the market until the company can persuade US regulators that it won't cause more deaths, according to an official familiar with the situation. Dow Inc. slumped after the chemical company reported its first quarterly loss in five years as trade and tariff uncertainties weighed on volumes. T-Mobile US Inc., the nation's second-largest wireless provider, reported more new subscribers than analysts were expecting in the second quarter, overcoming a sluggish start to the year. Chipotle Mexican Grill Inc. cut its annual outlook for the second time this year, suggesting that honey chicken and burrito giveaways haven't been enough to offset a traffic slump that the company attributed to economic anxiety. Blackstone Inc. reported a 25% jump in distributable earnings for the second quarter, buoyed by profits from its retail and evergreen funds. ServiceNow Inc. gave a strong outlook for revenue growth in the third quarter and touted customer adoption of its artificial intelligence software tools. Roche Holding AG is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer. Some of the main moves in markets: Stocks The S&P 500 rose 0.2% as of 1:02 p.m. New York time The Nasdaq 100 rose 0.3% The Dow Jones Industrial Average fell 0.5% The MSCI World Index rose 0.3% Bloomberg Magnificent 7 Total Return Index fell 0.3% The Russell 2000 Index fell 1.1% Alphabet rose 0.7% Tesla fell 9.1% Currencies The Bloomberg Dollar Spot Index rose 0.2% The euro was little changed at $1.1762 The British pound fell 0.5% to $1.3511 The Japanese yen fell 0.2% to 146.87 per dollar Cryptocurrencies Bitcoin rose 0.5% to $118,582.31 Ether rose 3.4% to $3,691.61 Bonds The yield on 10-year Treasuries advanced two basis points to 4.40% Germany's 10-year yield advanced six basis points to 2.70% Britain's 10-year yield declined one basis point to 4.62% The yield on 2-year Treasuries advanced four basis points to 3.92% The yield on 30-year Treasuries was little changed at 4.94% Commodities West Texas Intermediate crude rose 0.4% to $65.48 a barrel Spot gold fell 0.6% to $3,366.73 an ounce Burning Man Is Burning Through Cash Elon Musk's Empire Is Creaking Under the Strain of Elon Musk It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan A Rebel Army Is Building a Rare-Earth Empire on China's Border How Hims Became the King of Knockoff Weight-Loss Drugs ©2025 Bloomberg L.P. Sign in to access your portfolio
